Ciprofloxacin Lactate NEW

Manufacturer Provide Veterinary Medicine CAS97867-33-9 Ciprofloxacin Lactate 

Introduction

Product Name: Ciprofloxacin Lactate

C.A.S NO. :97867-33-9

Assay (%)(HPLC, Basis on drying):99%

Molecular formula: C20H24FN3O6

Appearance: White Powder

Melting Point :255-257°C

Molecular weight :421.43

Storage Condition: Store in cool and dry places ,keep away from strong light 

Ciprofloxacin Lactate is a synthetic third-generation quinolone antibacterial drug with broad-spectrum antibacterial activity and good bactericidal effect. Its antibacterial activity is almost 2-4 times stronger than that of norfloxacin and enoxacin for almost all bacteria. Enterobacter, Pseudomonas aeruginosa, Haemophilus influenzae, Neisseria gonorrhoeae, Streptococcus, Legionella, Staphylococcus aureus has antibacterial activity.

Ciprofloxacin Lactate is a highly effective broad-spectrum antibiotic.Pharmacological effects are fluoroquinolones, antibacterial spectrum with norfloxacin, its antibacterial activity is currently the most widely used fluoroquinolones.

Application
Ciprofloxacin Lactate Ciprofloxacin is a synthetic third-generation quinolone antibacterial drug with broad-spectrum antibacterial activity and good bactericidal effect. Its antibacterial activity is almost 2-4 times stronger than that of norfloxacin and enoxacin for almost all bacteria. Enterobacter, Pseudomonas aeruginosa, Haemophilus influenzae, Neisseria gonorrhoeae, Streptococcus, Legionella, Staphylococcus aureus has antibacterial activity.

Function
Ciprofloxacin lactate is antimicrobials.Used for urinary reproductive system caused by sensitive bacteria infection,
including simple and complicated urinary tract infection, bacterial prostatitis, bacteria neisseria gonorrhea urethritis and cervicitis (including enzyme production strains caused by).Can also be treatment of respiratory tract infection, including sensitive acute bronchial infection caused by gram-negative bacilli and lung infection.Treatment of gastrointestinal tract infection by shigella, salmonella and e. coli to produce enterotoxin, moisture, deputy hemolytic bacterium vibrio, etc.Can the treatment of typhoid fever, bone and joint infection, skin soft tissue infection sepsis systemic infection, etc.